Shopping Cart (0)
My Account

Shopping Cart
SELECTBIO Conferences Antibody Drug Conjugates

Antibody Drug Conjugates

Date: Thursday, 24 May 2018 - Friday, 25 May 2018
Location: Bengaluru

Keynote Speakers

Nitin Damle

Nitin Damle
Senior Vice President and Head, Discovery Biology/ CSO, Sun Pharma Advanced Research Company Limited

Dimiter Stanchev Dimitrov

Dimiter Stanchev Dimitrov
Professor, University of Pittsburgh

Rajan Dighe

Rajan Dighe
Professor, Indian Institute of Science

Satish Singh

Satish Singh
Head, Lonza Inc


SELECTBIO brings to you its 3rd International conference on ADC Development & Manufacture "Antibody Drug Conjugates" on May 24-25, 2018 in Bengaluru, India.

An innovative therapeutic application which combines the distinctive properties of monoclonal antibodies (mAbs) with the potent cytotoxic effect of small drug molecules is Antibody-drug conjugates or ADCs. This conference will be covering different aspects of ADC development and manufacture, right from the introduction to regulatory thereby ensuring comprehensive understanding of the subject. In addition this event will provide an excellent platform for knowledge sharing, collaborative research and networking with the scientists in the field of Antibody Engineering, Antibody drug conjugates, biopharmaceuticals and Cancer research.

This event is co-located with our International Conference Biomarkers- From Research to Commercialization

Running alongside the conferences will be an exhibition covering the latest advancements & instrumentations in the related research area.

Venue and Date: Bengaluru, May 24-25, 2018

Sponsorship Options: Companies willing to participate in this event as Sponsors should contact the Exhibition Manager. Sponsorship options with Delegate Participation are also available.

Call for Papers

If you would like to be considered for an oral presentation at this meeting, Submit an abstract for review now!

Oral Presentation Submission Deadline: 30 April 2018

Agenda Topics

  • ADC Development - Issues and Challenges
  • ADC Formulation Development
  • Antibody Development & Engineering
  • Bioanalytical Strategies for ADCs
  • Novel Conjugation Technologies, Payload & Linkers
  • Strategies for Development of Specific and Targeted ADCs

Sponsorship and Exhibition Opportunities

Maninderjit Singh, Exhibition Manager

Confirmed Speakers to date

Sanjeev Gupta, Dy. General Manager & Head- Advanced Biotech Lab (CRD) , Ipca Laboratories Ltd.
Amy Han, Director, Chemistry, Regeneron Pharmaceuticals
Jagdish Nigade, Group Medical Manager, Roche
Sanjay Nilapwar, Senior Research Investigator, Incyte Corporation

Invited Speakers

Anthony DeBoer, Director, Business Development, Synaffix BV
Julia Gavrilyuk, Associate Director, Discovery Chemistry, Abbvie Stemcentrx
Andrew Huang, Chief Scientific Officer, Mabplex
Ian Schwartz, Consultant - CMC expert, Antibody Drug Conjugate and Upstream/Downstream , Sartorius Stedim Biotech

Exhibition Sponsors Media Sponsors Official Journal Partner Networking
Drug Discovery WoMetaTagsrld U-Networks

Add to Calendar ▼2018-05-24 00:00:002018-05-25 00:00:00Europe/LondonAntibody Drug ConjugatesAntibody Drug Conjugates in